Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02609984
Title Trial of CMB305 and Atezolizumab in Patients With Sarcoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Immune Design
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Palo Alto California 94304 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
MedStar Washington Hospital Center Washington District of Columbia 20010 United States Details
Mayo Clinic of Jacksonville Jacksonville Florida 32224 United States Details
Georgia Cancer Specialists Sandy Springs Georgia 30342 United States Details
Northwestern University Feinburg School of Medicine Chicago Illinois 60611 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Mayo Clinic Rochester Rochester Minnesota 10029 United States Details
Washington University in St. Louis Saint Louis Missouri 63110 United States Details
Monter Cancer Research Lake Success New York 11042 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Fox Chase cancer Center Philadelphia Pennsylvania 19111 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
University of Vermont Cancer Center Burlington Vermont 05405 United States Details
Scca/Fhcrc Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field